By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...